ZUNOVO Trademark

Trademark Overview

On Tuesday, April 25, 2023, a trademark application was filed for ZUNOVO with the United States Patent and Trademark Office. The USPTO has given the ZUNOVO trademark a serial number of 97906648. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Monday, February 9, 2026. This trademark is owned by Genentech, Inc.. The ZUNOVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of immune diseases and disorders and inflammatory diseases and disorders
zunovo

General Information

Serial Number97906648
Word MarkZUNOVO
Filing DateTuesday, April 25, 2023
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateMonday, February 9, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 19, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of immune diseases and disorders and inflammatory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 23, 2023
Primary Code005
First Use Anywhere DateWednesday, September 25, 2024
First Use In Commerce DateMonday, September 30, 2024

Trademark Owner History

Party NameGenentech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGenentech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Friday, April 28, 2023NEW APPLICATION ENTERED
Tuesday, May 23, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 13, 2023ASSIGNED TO EXAMINER
Monday, November 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 19, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 19, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 3, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 1, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 1, 2024SOU EXTENSION 1 FILED
Thursday, August 1, 2024SOU EXTENSION 1 GRANTED
Thursday, August 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 4, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, February 5, 2025SOU EXTENSION 2 FILED
Wednesday, February 5, 2025SOU EXTENSION 2 GRANTED
Wednesday, February 5, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 28, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 28, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 28, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 28, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, August 6, 2025TEAS STATEMENT OF USE RECEIVED
Wednesday, August 6, 2025USE AMENDMENT FILED
Monday, February 9, 2026STATEMENT OF USE PROCESSING COMPLETE

Related Keywords

zunovo diseases disorders inflammatory immune preparations treatment pharmaceutical